Literature DB >> 32426113

Could pulmonary arterial hypertension patients be at a lower risk from severe COVID-19?

Evelyn M Horn1, Murali Chakinala2, Ronald Oudiz3, Elizabeth Joseloff4, Erika B Rosenzweig5.   

Abstract

Entities:  

Year:  2020        PMID： 32426113      PMCID： PMC7219006          DOI： 10.1177/2045894020922799

Source DB:  PubMed          Journal:  Pulm Circ        ISSN： 2045-8932            Impact factor:   3.017


× No keyword cloud information.
  5 in total

1.  Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies.

Authors:  E Cozzi; F Calabrese; M Schiavon; P Feltracco; M Seveso; C Carollo; M Loy; M Cardillo; F Rea
Journal:  Am J Transplant       Date:  2016-10-31       Impact factor: 8.086

2.  Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.

Authors:  R R Wenzel; J Rüthemann; H Bruck; R F Schäfers; M C Michel; T Philipp
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

3.  Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection.

Authors:  John R Teijaro; Kevin B Walsh; Stuart Cahalan; Daniel M Fremgen; Edward Roberts; Fiona Scott; Esther Martinborough; Robert Peach; Michael B A Oldstone; Hugh Rosen
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

Review 4.  The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.

Authors:  Agata Kowalczyk; Paulina Kleniewska; Michal Kolodziejczyk; Beata Skibska; Anna Goraca
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-10-07       Impact factor: 4.291

5.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582
  5 in total
  19 in total

1.  [Pulmonary arterial hypertension and COVID-19].

Authors:  M L Avellanas Chavala
Journal:  Med Intensiva (Engl Ed)       Date:  2020-05-28

Review 2.  Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.

Authors:  Kanza N Qaiser; James E Lane; Adriano R Tonelli
Journal:  Pulm Circ       Date:  2020-09-16       Impact factor: 3.017

3.  Cardiac workup and monitoring in hospitalised children with COVID- 19.

Authors:  Michael A Fremed; Irene D Lytrivi; Leonardo Liberman; Brett R Anderson; Oliver M Barry; Tarif A Choudhury; Sophia Chrisomalis-Dring; Anne Ferris; Julie S Glickstein; Usha Krishnan; Stéphanie Levasseur; Erika B Rosenzweig; Amee Shah; Eric S Silver; Sanghee Suh; Mariel E Turner; Rachel Weller; Joyce Woo; Thomas J Starc
Journal:  Cardiol Young       Date:  2020-07-02       Impact factor: 1.093

4.  Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.

Authors:  Elisabeth Fließer; Anna Birnhuber; Leigh M Marsh; Elisabeth Gschwandtner; Walter Klepetko; Horst Olschewski; Grazyna Kwapiszewska
Journal:  J Pathol Clin Res       Date:  2021-05-12

5.  COVID-19 and the pulmonary vasculature.

Authors:  Steeve Provencher; François Potus; Sébastien Bonnet
Journal:  Pulm Circ       Date:  2020-06-10       Impact factor: 3.017

6.  Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19.

Authors:  Veronica Franco; Elisa A Bradley; Roberto Badagliacca; Aarthi Sabanayagam; Saurabh Rajpal; Lauren T Lastinger; Curt J Daniels; J Shaun Smith; Raymond L Benza
Journal:  Pulm Circ       Date:  2020-11-20       Impact factor: 3.017

Review 7.  Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.

Authors:  Harry Karmouty-Quintana; Rajarajan A Thandavarayan; Steven P Keller; Sandeep Sahay; Lavannya M Pandit; Bindu Akkanti
Journal:  Int J Mol Sci       Date:  2020-10-29       Impact factor: 5.923

8.  COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey.

Authors:  Catharina Belge; Rozenn Quarck; Laurent Godinas; David Montani; Pilar Escribano Subias; Jean-Luc Vachiéry; Heba Nashat; Joanna Pepke-Zaba; Marc Humbert; Marion Delcroix
Journal:  ERJ Open Res       Date:  2020-11-02

Review 9.  Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome.

Authors:  Reece P Stevens; Sunita S Paudel; Santina C Johnson; Troy Stevens; Ji Young Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-23       Impact factor: 6.011

Review 10.  Sex-related differences in COVID-19 lethality.

Authors:  Claudia Penna; Valentina Mercurio; Carlo G Tocchetti; Pasquale Pagliaro
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 9.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.